|Articles|August 1, 2002
Agreement announced: InSite Vision to help find test for PCG detection
Alameda, CA-InSite Vision Inc. has joined forces with an unnamed diagnostics company to develop a commercial assay to detect genetic mutations associated with primary congenital glaucoma (PCG).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
























